Fresenius Medical Care AG
FME: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| Zg> | LOCK|%M!J | LOCK|H?G@?h |
Fresenius Medical Care Earnings: Ongoing Margin Expansion Keeps Long-Term Outlook Intact
In the third quarter, Fresenius Medical Care generated 10% organic revenue growth and adjusted earnings per share growth of 37%. Management confirmed its guidance for 2025.
